Bayer funds educational projects to advance treatment strategies and clinical trial innovations in metastatic hormone-sensitive prostate cancer (mHSPC).
Bayer funds educational initiatives advancing clinical knowledge and care in advanced prostate cancer, focusing on recent research, evidence gaps, and survivorship using innovative formats.
Bayer funds educational initiatives to enhance quality of life and patient-centered care in advanced prostate cancer, focusing on evidence-based approaches, cognitive outcomes, and survivorship.
Bayer funds educational programs advancing knowledge of new therapies, treatment strategies, and quality of life in advanced prostate cancer.
Biomarker Accelerator Grant Program supports researchers translating and validating existing PSP biomarkers for research and clinical use, aiming to improve diagnosis, monitoring and treatment-response assessment.
Annual grant supporting innovative research to advance understanding, diagnosis, and treatment of multiple system atrophy, cerebellar subtype (MSA-C).